Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific...

Details werden geladen...

https://www.manilatimes.net/2026/06/05/tmt-newswire/globenewswire/eledon-announces-presentation-of-updated-data-from-investigator-initiated-islet-transplant-trial-of-tegoprubart-in-patients-with-type-1-diabetes-at-american-diabetes-association-ada-2026-scientific-sessions/2359225

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific...

IRVINE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ('Eledon”) (Nasdaq: ELDN) today announced that updated results from an investigator-initiated trial being conducted at the University of Chicago Medicine Transplant Institute will be presented by Piotr Witkowski, M.D., Ph.D., Director of the Pancreas and Islet Transplant Program at UChicago Medicine, at the American Diabetes Association 86th Scientific Sessions, taking place June 5-9, 2026, in New Orleans, Louisiana.

New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people l...

https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/new-data-from-phase-2-zupreme-1-trial-at-the-american-diabetes-association-2026-scientific-sessions-further-support-potential-of-petrelintide-to-redefine-the-weight-management-experience-for-people-living-with-overweight-and-obesity/2359876

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association ("ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Stud...

https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/biomea-fusion-presents-new-clinical-and-translational-data-for-icovamenib-at-the-american-diabetes-association-ada-86th-scientific-sessions-and-announces-expansion-of-ongoing-phase-i-bmf-650-study/2359908

Verdiva Bio Limited: Verdiva Bio Presents Preclinical Data on Investigational Obesity Drug Candidates at the American Diabetes Association 86th Scientific Sessions

https://www.finanznachrichten.de/nachrichten-2026-06/68696937-verdiva-bio-limited-verdiva-bio-presents-preclinical-data-on-investigational-obesity-drug-candidates-at-the-american-diabetes-association-86th-scient-004.htm

Rivus Pharmaceuticals Announces Preclinical Data for RV-8451, a Muscle-Preserving, Oral GLP-1, at ADA 2026 Scientific Sessions | The Manila Times

https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/rivus-pharmaceuticals-announces-preclinical-data-for-rv-8451-a-muscle-preserving-oral-glp-1-at-ada-2026-scientific-sessions/2359840

Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions | The Manila Times

https://www.manilatimes.net/2026/05/29/tmt-newswire/pr-newswire/innogen-to-present-phase-iib-enlight-study-results-for-efsubaglutide-alfa-at-the-2026-ada-scientific-sessions/2354621

Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress | The Manila ...

https://www.manilatimes.net/2026/05/21/tmt-newswire/globenewswire/eledon-pharmaceuticals-to-present-new-long-term-data-from-phase-2-bestow-trial-of-tegoprubart-for-the-prevention-of-rejection-in-kidney-transplantation-at-american-transplant-congress/2348640

Login